東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Pharmacology/Toxicology." ]

切換: 標籤 | MARC模式 | ISBD

Systemic vasculitides = current stat...

Dammacco, Franco.

FindBook

Google Book

Amazon

博客來

Systemic vasculitides = current status and perspectives /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Systemic vasculitides/ edited by Franco Dammacco, Domenico Ribatti, Angelo Vacca.
其他題名:	current status and perspectives /
其他作者:	Dammacco, Franco.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xi, 438 p. :ill., digital ;24 cm.
內容註:	Preface -- Introductory remarks -- Giant Cell Arteritis -- Takayasu Arteritis -- Polyarteritis Nodosa -- Mechanisms of ANCA-Associated Vasculitides -- Granulomatosis with Polyangiitis (Wegener's) and Similar "AAV with Probable Etiology" -- Eosinophilic Granulomatosis with Polyangiitis (Churg Strauss) -- Anti-Glomerular Basement Membrane Disease -- IgA Vasculitis -- HCV-Related Cryoglobulinemic Vasculitis -- Vasculitis and Pulmonary Hypertension: New Therapeutic Approaches -- Vasculitis in SLE, RA and Other Connective Tissue Diseases: Diagnosis and Treatment -- Central Nervous System Vasculitis -- Uveitis -- IgG4 Syndrome -- Behcet Syndrome -- Urticarioid Vasculitis -- Guidelines for the Diagnosis and Treatment of Vasculitides -- Index.
Contained By:	Springer eBooks
標題:	Vasculitis. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-40136-2
ISBN:	9783319401362

Systemic vasculitides = current status and perspectives /
Systemic vasculitidescurrent status and perspectives /[electronic resource] :edited by Franco Dammacco, Domenico Ribatti, Angelo Vacca. - Cham :Springer International Publishing :2016. - xi, 438 p. :ill., digital ;24 cm.

Preface -- Introductory remarks -- Giant Cell Arteritis -- Takayasu Arteritis -- Polyarteritis Nodosa -- Mechanisms of ANCA-Associated Vasculitides -- Granulomatosis with Polyangiitis (Wegener's) and Similar "AAV with Probable Etiology" -- Eosinophilic Granulomatosis with Polyangiitis (Churg Strauss) -- Anti-Glomerular Basement Membrane Disease -- IgA Vasculitis -- HCV-Related Cryoglobulinemic Vasculitis -- Vasculitis and Pulmonary Hypertension: New Therapeutic Approaches -- Vasculitis in SLE, RA and Other Connective Tissue Diseases: Diagnosis and Treatment -- Central Nervous System Vasculitis -- Uveitis -- IgG4 Syndrome -- Behcet Syndrome -- Urticarioid Vasculitis -- Guidelines for the Diagnosis and Treatment of Vasculitides -- Index.

The systemic vasculitides,includinglarge, medium, small, and variable vessel vasculitis,have been the focus of intensive basic and clinical investigations over the last twodecades. Among theimportant advances stemming from these efforts are new definitions, classifications, and diagnostic criteria for the different classes of vasculitis; the addition of anti-neutrophil cytoplasmic autoantibodies as a new criterion for classifying vasculitis; the recognition of the viral etiology of conditions such as cryoglobulinemic vasculitis and polyarteritis nodosa; an appreciation of thebroad spectrum of clinical manifestations and potentially devastating complicationsassociated with vasculitis; the many features and remarkable clinical heterogeneity of IgG4-related, immune-mediated diseases; and the proposal of intriguing pathogenetic hypotheses for certain chronic, relapsing vasculitides. This improved understanding of the systemic vasculitides has been accompanied by a trend away from the use of eponyms for these conditions; thus, established terms such as Wegener's granulomatosis and Churg-Strauss syndrome have been replacedby the more descriptive definitions "granulomatosis with polyangiitis" and "eosinophilic granulomatosis with polyangiitis," respectively. Additional clinical laboratory tests,rapidly developing imaging techniques that can assess inflammation, especially in large-vessel vasculitis, and artificial neural network approaches will no doubt bring a wealth of informationthat ultimately leads to the identification of novel disease biomarkers. Expected applications include the identification of individuals at increased risk ofrelapsewho would benefit from patient-tailored therapy. Although the conventional combination of glucocorticoids and immunosuppressive drugs is effective in the treatment of a large proportion of vasculitic disorders, safer medications, with fewer side effects, are being developed, includingseveral biological agents now being closely evaluated in multi-center studies. This volume brings togethercomprehensive and up-to-date reviews written by experiencedscientists and clinicians from many countries. Its aim is toprovide readers with state-of-the-art knowledge of the major vasculitides and cutting-edge insights into their multi-faceted features. It is our hope that this book serves as a valuable and stimulating resourcefor basic and clinical researchers, specialists in related disciplines, as well as practicing physicians and advanced medical students interested in this fascinating branch of pathology. Franco Dammacco, Domenico Ribatti, Angelo Vacca.

ISBN: 9783319401362

Standard No.: 10.1007/978-3-319-40136-2doiSubjects--Topical Terms:

891325
Vasculitis.

LC Class. No.: RC694.5.I53

Dewey Class. No.: 616.13

Systemic vasculitides = current status and perspectives /
LDR:04350nmm a2200313 a 4500 001 2053472
003 DE-He213
005 20161013162730.0
006 m d
007 cr nn 008maaau
008 170510s2016 gw s 0 eng d
020 $a 9783319401362 $q (electronic bk.)
020 $a 9783319401348 $q (paper)
024 7 $a 10.1007/978-3-319-40136-2 $2 doi
035 $a 978-3-319-40136-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC694.5.I53
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.13 $2 23
090 $a RC694.5.I53 $b S995 2016
245 0 0 $a Systemic vasculitides $h [electronic resource] : $b current status and perspectives / $c edited by Franco Dammacco, Domenico Ribatti, Angelo Vacca.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xi, 438 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- Introductory remarks -- Giant Cell Arteritis -- Takayasu Arteritis -- Polyarteritis Nodosa -- Mechanisms of ANCA-Associated Vasculitides -- Granulomatosis with Polyangiitis (Wegener's) and Similar "AAV with Probable Etiology" -- Eosinophilic Granulomatosis with Polyangiitis (Churg Strauss) -- Anti-Glomerular Basement Membrane Disease -- IgA Vasculitis -- HCV-Related Cryoglobulinemic Vasculitis -- Vasculitis and Pulmonary Hypertension: New Therapeutic Approaches -- Vasculitis in SLE, RA and Other Connective Tissue Diseases: Diagnosis and Treatment -- Central Nervous System Vasculitis -- Uveitis -- IgG4 Syndrome -- Behcet Syndrome -- Urticarioid Vasculitis -- Guidelines for the Diagnosis and Treatment of Vasculitides -- Index.
520 $a The systemic vasculitides,includinglarge, medium, small, and variable vessel vasculitis,have been the focus of intensive basic and clinical investigations over the last twodecades. Among theimportant advances stemming from these efforts are new definitions, classifications, and diagnostic criteria for the different classes of vasculitis; the addition of anti-neutrophil cytoplasmic autoantibodies as a new criterion for classifying vasculitis; the recognition of the viral etiology of conditions such as cryoglobulinemic vasculitis and polyarteritis nodosa; an appreciation of thebroad spectrum of clinical manifestations and potentially devastating complicationsassociated with vasculitis; the many features and remarkable clinical heterogeneity of IgG4-related, immune-mediated diseases; and the proposal of intriguing pathogenetic hypotheses for certain chronic, relapsing vasculitides. This improved understanding of the systemic vasculitides has been accompanied by a trend away from the use of eponyms for these conditions; thus, established terms such as Wegener's granulomatosis and Churg-Strauss syndrome have been replacedby the more descriptive definitions "granulomatosis with polyangiitis" and "eosinophilic granulomatosis with polyangiitis," respectively. Additional clinical laboratory tests,rapidly developing imaging techniques that can assess inflammation, especially in large-vessel vasculitis, and artificial neural network approaches will no doubt bring a wealth of informationthat ultimately leads to the identification of novel disease biomarkers. Expected applications include the identification of individuals at increased risk ofrelapsewho would benefit from patient-tailored therapy. Although the conventional combination of glucocorticoids and immunosuppressive drugs is effective in the treatment of a large proportion of vasculitic disorders, safer medications, with fewer side effects, are being developed, includingseveral biological agents now being closely evaluated in multi-center studies. This volume brings togethercomprehensive and up-to-date reviews written by experiencedscientists and clinicians from many countries. Its aim is toprovide readers with state-of-the-art knowledge of the major vasculitides and cutting-edge insights into their multi-faceted features. It is our hope that this book serves as a valuable and stimulating resourcefor basic and clinical researchers, specialists in related disciplines, as well as practicing physicians and advanced medical students interested in this fascinating branch of pathology. Franco Dammacco, Domenico Ribatti, Angelo Vacca.
650 0 $a Vasculitis. $3 891325
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Immunology. $3 611031
650 2 4 $a Neurosciences. $3 588700
650 2 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Virology. $3 642304
700 1 $a Dammacco, Franco. $3 1566826
700 1 $a Ribatti, Domenico. $3 1001537
700 1 $a Vacca, Angelo. $3 3166268
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-40136-2
950 $a Biomedical and Life Sciences (Springer-11642)